| Document Date: 2009-10-23 10:59:12
Open Document File Size: 204,34 KBShare Result on Facebook
Company Paddock Laboratories Inc. / AstraZeneca / / Event Product Issues / / Facility Laboratory Test Findings / / IndustryTerm Treatment of heart failure / food / Treatment of hypertension / / MedicalCondition In heart failure / pediatric hypertension / headache / mg/kg oral suspension Hypertension / INDICATIONS AND USAGE Hypertension ATACAND / sustained irreversible injury / rhinitis / Known hypersensitivity / irreversible renal failure / fetal and neonatal injury / injury / left ventricular systolic dysfunction / back pain / upper respiratory tract infection / bilateral renal artery stenosis / Hypotension / hyperkalemia leading / severe heart failure / mg tablet Hypertension / Hyperkalemia / Adult Hypertension / intrauterine growth retardation / Surgery/Anesthesia Hypotension / hypertension / Adult Heart Failure / hydronephrosis / patent ductus arteriosus / Carcinogenesis / symptomatic hypotension / oliguria / Contraction / Adult Hypertension ATACAND / progressive azotemia / heart failure / divided dose Adult Heart Failure / fetal limb contractures / Oligohydramnios / dizziness / anuria / pharyngitis / acute renal failure / / MedicalTreatment intravenous infusion / Major Surgery / dialysis / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Position Major / / Product Hypertension / Adult 16 mg / Oral Suspension / ATACAND / Adult Heart Failure 4 / candesartan cilexetil / spironolactone / Pediatric mg / renal function / / Technology ultrasound / Geriatrics / Pharmacokinetics / Pharmacodynamics / dialysis / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ATACAND safely and effectively. See full prescribing information for